TaiMed Biologics (Taiwan) Buy Hold or Sell Recommendation
| 4147 Stock | TWD 92.50 0.90 0.98% |
Assuming the 90 days trading horizon and your above-average risk tolerance, our recommendation regarding TaiMed Biologics is 'Hold'. A buy or sell recommendation is an automated directive regarding whether to purchase or sell TaiMed Biologics given historical horizon and risk tolerance. When we issue a 'buy' or 'sell' recommendation for TaiMed Biologics, the advice is generated through an automated system that utilizes algorithms and statistical models.
Check out TaiMed Biologics Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. Note, we conduct extensive research on individual companies such as TaiMed and provide practical buy, sell, or hold advice based on investors' constraints. TaiMed Biologics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
TaiMed |
Execute TaiMed Biologics Buy or Sell Advice
The TaiMed recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on TaiMed Biologics. Macroaxis does not own or have any residual interests in TaiMed Biologics or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute TaiMed Biologics' advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Hold
Market Performance | OK | Details | |
Volatility | Very steady | Details | |
Hype Condition | Stale | Details | |
Current Valuation | Fairly Valued | Details | |
Odds Of Distress | Low | Details | |
Economic Sensitivity | Barely shadows the market | Details | |
Analyst Consensus | Not Available | Details | |
Reporting Quality (M-Score) | Inapplicable | Details |
TaiMed Biologics Trading Alerts and Improvement Suggestions
| The company reported the revenue of 413.44 M. Net Loss for the year was (470.93 M) with profit before overhead, payroll, taxes, and interest of 177.82 M. | |
| TaiMed Biologics has accumulated about 1.02 B in cash with (211.28 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 4.03. | |
| Roughly 17.0% of the company shares are owned by insiders or employees |
TaiMed Biologics Returns Distribution Density
The distribution of TaiMed Biologics' historical returns is an attempt to chart the uncertainty of TaiMed Biologics' future price movements. The chart of the probability distribution of TaiMed Biologics daily returns describes the distribution of returns around its average expected value. We use TaiMed Biologics price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of TaiMed Biologics returns is essential to provide solid investment advice for TaiMed Biologics.
| Mean Return | 0.17 | Value At Risk | -3.19 | Potential Upside | 4.15 | Standard Deviation | 2.55 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of TaiMed Biologics historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
TaiMed Biologics Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to TaiMed Biologics or Biotechnology sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that TaiMed Biologics' price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a TaiMed stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over Dow Jones | 0.17 | |
β | Beta against Dow Jones | 0.06 | |
σ | Overall volatility | 2.61 | |
Ir | Information ratio | 0.11 |
TaiMed Biologics Volatility Alert
TaiMed Biologics currently demonstrates below-average downside deviation. It has Information Ratio of 0.11 and Jensen Alpha of 0.17. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure TaiMed Biologics' stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact TaiMed Biologics' stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.TaiMed Biologics Fundamentals Vs Peers
Comparing TaiMed Biologics' fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze TaiMed Biologics' direct or indirect competition across all of the common fundamentals between TaiMed Biologics and the related equities. This way, we can detect undervalued stocks with similar characteristics as TaiMed Biologics or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of TaiMed Biologics' fundamental indicators could also be used in its relative valuation, which is a method of valuing TaiMed Biologics by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare TaiMed Biologics to competition |
| Fundamentals | TaiMed Biologics | Peer Average |
| Return On Equity | -0.18 | -0.31 |
| Return On Asset | -0.062 | -0.14 |
| Profit Margin | (1.70) % | (1.27) % |
| Operating Margin | (1.47) % | (5.51) % |
| Current Valuation | 17.73 B | 16.62 B |
| Shares Outstanding | 252.37 M | 571.82 M |
| Shares Owned By Insiders | 17.27 % | 10.09 % |
| Shares Owned By Institutions | 21.66 % | 39.21 % |
| Price To Book | 6.45 X | 9.51 X |
| Price To Sales | 55.99 X | 11.42 X |
| Revenue | 413.44 M | 9.43 B |
| Gross Profit | 177.82 M | 27.38 B |
| EBITDA | (306.83 M) | 3.9 B |
| Net Income | (470.93 M) | 570.98 M |
| Cash And Equivalents | 1.02 B | 2.7 B |
| Cash Per Share | 4.03 X | 5.01 X |
| Total Debt | 536 M | 5.32 B |
| Debt To Equity | 0.20 % | 48.70 % |
| Current Ratio | 10.64 X | 2.16 X |
| Book Value Per Share | 10.88 X | 1.93 K |
| Cash Flow From Operations | (211.28 M) | 971.22 M |
| Earnings Per Share | (2.36) X | 3.12 X |
| Target Price | 88.0 | |
| Number Of Employees | 37 | 18.84 K |
| Beta | 0.51 | -0.15 |
| Market Capitalization | 17.62 B | 19.03 B |
| Total Asset | 4.61 B | 29.47 B |
| Z Score | 19.2 | 8.72 |
| Net Asset | 4.61 B |
TaiMed Biologics Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as TaiMed . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
About TaiMed Biologics Buy or Sell Advice
When is the right time to buy or sell TaiMed Biologics? Buying financial instruments such as TaiMed Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having TaiMed Biologics in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Alternative Currency ETFs Thematic Idea Now
Alternative Currency ETFs
ETF themes focus on helping investors to gain exposure to a broad range of assets, diversify, and lower overall costs. The Alternative Currency ETFs theme has 55 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Alternative Currency ETFs Theme or any other thematic opportunities.
| View All Next | Launch |
Additional Tools for TaiMed Stock Analysis
When running TaiMed Biologics' price analysis, check to measure TaiMed Biologics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy TaiMed Biologics is operating at the current time. Most of TaiMed Biologics' value examination focuses on studying past and present price action to predict the probability of TaiMed Biologics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move TaiMed Biologics' price. Additionally, you may evaluate how the addition of TaiMed Biologics to your portfolios can decrease your overall portfolio volatility.